Assessment of the Risk for Venous Thromboembolism Among Users of Hormone Replacement Therapy

ISSN： 1170-229X

Source： Drugs & Aging, Vol.14, Iss.1, 1999-01, pp. : 55-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Epidemiological Studies of the Association Between Hormone Replacement Therapy and Venous Thromboembolism: A Review

By Castellsague J.

Drug Safety, Vol. 18, Iss. 2, 1998-02 ,pp. : 117-123

Adis International

Access to resources Recommend Favorite

Hormone Replacement Therapy in Postmenopausal Women With Diabetes Mellitus: A Risk-Benefit Assessment

By Andersson B.

Drugs & Aging, Vol. 17, Iss. 5, 2000-11 ,pp. : 399-410

Adis International

Access to resources Recommend Favorite

Risk of venous thromboembolism due to antipsychotic drug therapy

By Hägg Staffan Jönsson Anna K Spigset Olav

Expert Opinion on Drug Safety, Vol. 8, Iss. 5, 2009-09 ,pp. : 537-547

Informa Healthcare

Access to resources Recommend Favorite

A Benefit-Risk Assessment of Dabigatran in the Prevention of Venous Thromboembolism in Orthopaedic Surgery

By Schulman Sam Majeed Ammar

Drug Safety, Vol. 34, Iss. 6, 2011-06 ,pp. : 449-463

Adis International

Access to resources Recommend Favorite

Bevacizumab: increased risk of venous thromboembolism

Reactions Weekly, Vol. 1, Iss. 1230, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite